Literature DB >> 2805426

Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis.

A H Heurkens1, P S Hiemstra, G J Lafeber, M R Daha, F C Breedveld.   

Abstract

IgG antibodies reactive with human umbilical vein endothelial cells were found in 19 out of 28 patients with rheumatoid vasculitis (RV), in four out of 24 patients with rheumatoid arthritis (RA), in seven out of 10 patients with systemic lupus erythematosus (SLE), but not in healthy donors. In four patients with RV who were followed longitudinally, regression of vasculitic episodes coincided with decreasing titres of anti-endothelial antibodies (AEA). Binding activity to endothelial cells was observed in intact IgG and F(ab')2 fragments of IgG. AEA activity was unrelated to antibodies against nuclear, blood group or major histocompatibility complex antigens and did not involve immune complexes. AEA activity was not specific for endothelial cells since the AEA-positive sera and the IgG fractions prepared from these sera also reacted with fibroblasts. Adsorption of positive sera and corresponding IgG fractions with endothelial cells decreased the IgG binding reactivity on both fibroblasts and endothelial cells. These findings show that RV patients have IgG-AEA, and suggest that these antibodies may play a role in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2805426      PMCID: PMC1534594     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  [PRESENCE OF THE RHEUMATOID FACTOR IN VASCULAR LESIONS IN CASES OF AGGRAVATED (MALIGNANT) RHEUMATOID ARTHRITIS. FLUORESCENT ANTIBODY STUDY].

Authors:  B PERNIS; C B BALLABIO; G CHIAPPINO
Journal:  Reumatismo       Date:  1963 May-Jun

2.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

3.  Cross--reactivity of antilymphocyte and antinuclear antibodies in systemic lupus erythematosus.

Authors:  R P Searles; R P Messner; A D Bankhurst
Journal:  Clin Immunol Immunopathol       Date:  1979-11

4.  Lactoperoxidase coupled to polyacrylamide for radio-iodination of proteins to high specific activity.

Authors:  J I Thorell; I Larsson
Journal:  Immunochemistry       Date:  1974-04

5.  Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases.

Authors:  D G Scott; P A Bacon; C R Tribe
Journal:  Medicine (Baltimore)       Date:  1981-07       Impact factor: 1.889

6.  Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis.

Authors:  C J Meijer; J Cnossen; G J Lafeber; M J Damsteeg; A Cats
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

7.  Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.

Authors:  A Brand; A van Leeuwen; J G Eernisse; J J van Rood
Journal:  Blood       Date:  1978-05       Impact factor: 22.113

8.  Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis.

Authors:  R J Rapoport; F Kozin; S E Mackel; R E Jordon
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

9.  Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection.

Authors:  R H Kauffmann; L A Van Es; M R Daha
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

10.  Sera from patients with systemic lupus erythematosus reactive with human endothelial cells.

Authors:  M Shingu; E R Hurd
Journal:  J Rheumatol       Date:  1981 Jul-Aug       Impact factor: 4.666

View more
  19 in total

1.  Detection of antiendothelial cell antibodies by an enzyme-linked immunosorbent assay using antigens from cell lysate: minimal interference with antinuclear antibodies and rheumatoid factors.

Authors:  Christian Drouet; Marie-France Nissou; Denise Ponard; Josiane Arvieux; Chantal Dumestre-Pérard; Philippe Gaudin; Bernard Imbert; Christian Massot; Françoise Sarrot-Reynauld
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 2.  Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE).

Authors:  D D'Cruz; M Khamashta; G Hughes
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 3.  Vasculitis associated with connective tissue disorders.

Authors:  Mittie K Doyle
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 4.  Anti-endothelial cell antibodies and autoimmune diseases.

Authors:  N Del Papa; D Gambini; P L Meroni
Journal:  Clin Rev Allergy       Date:  1994

5.  Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.

Authors:  R Cervera; M Navarro; A López-Soto; M C Cid; J Font; J Esparza; J C Reverter; J Monteagudo; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

6.  A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies.

Authors:  D W Koenig; L Barley-Maloney; T O Daniel
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

7.  Anti-endothelial cell antibodies in nephropathia epidemica and other viral diseases.

Authors:  A G Wangel; M Temonen; M Brummer-Korvenkontio; A Vaheri
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

8.  Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.

Authors:  C S Lau; M McLaren; J Hanslip; M Kerr; J J Belch
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

9.  Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells.

Authors:  W J Mayet; A Schwarting; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

10.  Serum immunoglobulin G reactive with endothelial cells in inflammatory bowel disease.

Authors:  A M Sawyerr; B E Pottinger; C O Savage; N J Bradley; M Hudson; A J Wakefield; J D Pearson; R E Pounder
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.